| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 02/01/2007 | CA2617082A1 Method for genetic immunization by electrotransfer against a toxin and antiserum obtainable by said method |
| 02/01/2007 | CA2617051A1 Ph-controlled pulsatile delivery system, methods for preparation and use thereof |
| 02/01/2007 | CA2616877A1 Systems and methods for manufacturing liposomes |
| 02/01/2007 | CA2616395A1 B-cell reduction using cd37-specific and cd20-specific binding molecules |
| 02/01/2007 | CA2616386A1 Single dose use of cd20-specific binding molecules |
| 02/01/2007 | CA2616099A1 Novel anti-igf-ir antibodies and uses thereof |
| 02/01/2007 | CA2615615A1 Anti-cd26 antibodies and methods of use thereof |
| 02/01/2007 | CA2588089A1 Immunogenic compositions containing anthrax antigen, biodegradable polymer microparticles, and polynucleotide-containing immunological adjuvant |
| 01/31/2007 | EP1748075A1 Recombinant chemokine-antigen vaccine |
| 01/31/2007 | EP1748070A1 Therapeutic medicine containing monoclonal antibody against folate receptor beta (fr-beta) |
| 01/31/2007 | EP1748065A2 Cell cycle progression proteins |
| 01/31/2007 | EP1747672A2 Method and formulation for transdermal delivery of immunologically active agents |
| 01/31/2007 | EP1747468A2 Disease related protein aggregation |
| 01/31/2007 | EP1747268A1 Process for the production of an influenza vaccine |
| 01/31/2007 | EP1747262A1 Conserved inner core lipopolysaccharide epitopes as multi-species vaccine candidates |
| 01/31/2007 | EP1747237A2 Fc gamma riib-specific antibodies and methods of use thereof |
| 01/31/2007 | EP1747234A1 A protein involved in cancer |
| 01/31/2007 | EP1747025A2 Method for diagnosing infectious diseases |
| 01/31/2007 | EP1747015A2 Solution phase biopanning method using engineered decoy proteins |
| 01/31/2007 | EP1747014A2 Modulation of lysophosphatidylcholine and treatment of diet-induced conditions |
| 01/31/2007 | EP1747013A2 Lipid-extracted therapeutic vaccine and method of use |
| 01/31/2007 | EP1747012A2 Preparation of salmonella broad-spectrum vaccines |
| 01/31/2007 | EP1747011A2 Means and method for diagnosis, prophylaxis and therapy of connective tissue diseases |
| 01/31/2007 | EP1536838B1 Hyposensibilisation by hydroxyalkyl starch allergen conjugates |
| 01/31/2007 | EP1240519B1 Compositions and methods for detecting treponema pallidum |
| 01/31/2007 | EP1200562B1 Cell lines, ligands and antibody fragments for use in pharmaceutical compositions for preventing and treating haemostasis disorders |
| 01/31/2007 | EP1034000B1 Method for obtaining vaccines for preventing the pathogenic effects related to a retroviral hiv infection |
| 01/31/2007 | CN1906491A Methods of screening using CTGF and TRKA receptor for the identification of compounds for use in treatment of fibrosis |
| 01/31/2007 | CN1906490A Biological materials and uses thereof |
| 01/31/2007 | CN1906302A Genetically modified plants comprising SARS-CoV viral nucleotide sequences and methods of use thereof for immunization against SARS |
| 01/31/2007 | CN1906301A HIV-1 Indian subtype C vaccine constructs for use in humans |
| 01/31/2007 | CN1906299A Immunization against chlamydia infection |
| 01/31/2007 | CN1906297A IL-23 and its receptor, related reagents and methods |
| 01/31/2007 | CN1906214A Anti-IGFR1 antibody therapeutic combinations |
| 01/31/2007 | CN1906211A Novel muscle growth regulator |
| 01/31/2007 | CN1906210A Surface-located campylobacter jejuni polypeptides |
| 01/31/2007 | CN1905921A Local intraosseous administration of bone forming agents and anti-resorptive agents and devices therefor |
| 01/31/2007 | CN1905903A Ghrelin-carrier conjugates |
| 01/31/2007 | CN1905900A Targeting of ERB antigens |
| 01/31/2007 | CN1905899A EphA2 agonistic monoclonal antibodies and methods of use thereof |
| 01/31/2007 | CN1905898A Anti-hydroxylase antibodies and uses thereof |
| 01/31/2007 | CN1905897A Antagonist anti-CD40 monoclonal antibodies and methods for their use |
| 01/31/2007 | CN1905896A Methods of enhancing immune response in the intradermal compartment and compounds useful thereof |
| 01/31/2007 | CN1905890A Pharmaceutical product comprising tissue of the male vegetal reproductive system |
| 01/31/2007 | CN1905842A Ultrasound assisted transdermal vaccine delivery method and system |
| 01/31/2007 | CN1905809A Method for improving body weight uniformity and increasing carcass yield in animals |
| 01/31/2007 | CN1904054A Poultry infectivity bronchitis DNA vaccine pIBM and application |
| 01/31/2007 | CN1904053A Fusion gene of Japan schistosome antigen gene and constituted DNA vaccin and preparing process |
| 01/31/2007 | CN1903881A Antitumour multitarget composite antigen, its coding gene and application |
| 01/31/2007 | CN1903880A Antitumour vascular endothelial growth factor VEGF-E antigen, its coding gene and application |
| 01/31/2007 | CN1903878A Anti SARS virus human source nature antibody IgG Fab section |
| 01/31/2007 | CN1903877A Antitumour vascular endothelial growth factor receptor VEGF-R antigen and its coding gene and application |
| 01/31/2007 | CN1903875A Antitumour integrator alpha V beta 3 antigen and its coding gene and application |
| 01/31/2007 | CN1903372A Three gene combination DNA vaccine for avian infectious bronchitis, and application thereof |
| 01/31/2007 | CN1903370A DNA vaccine pIBS1 for avian infectious bronchitis and application thereof |
| 01/31/2007 | CN1903363A Mosaic type virus-like particle DNA vaccine |
| 01/31/2007 | CN1297636C Fuel additive |
| 01/31/2007 | CN1297567C Double functional fusion protein possessing antineoplastic functions, method for making same and use thereof |
| 01/31/2007 | CN1297566C DNA for encoding the RGI polypeptide |
| 01/31/2007 | CN1297316C Mutant forms of cholera holotoxin as adjuvant |
| 01/31/2007 | CN1297315C Preparation method of anti prglet bacterial epidemic disease compound egg antibody medicinal preparation |
| 01/31/2007 | CN1297314C Method for cultivating attenuated strain pilio inactivated vaccine |
| 01/31/2007 | CN1297313C After treatment method for attenuated strain polio inactivated vaccine |
| 01/31/2007 | CN1297312C Recombinant phage vaccine of tumor proliferation related growth factor and its application |
| 01/31/2007 | CN1297281C Method for treatment of leukaemia |
| 01/30/2007 | US7169903 Killing gram positive bacteria in situ; vaccine |
| 01/30/2007 | US7169902 Collagen-binding proteins from Streptococcus pyogenes |
| 01/30/2007 | US7169780 N-substituted hydroxypyrimidinone carboxamide inhibitors of HIV integrase |
| 01/30/2007 | US7169751 combining a compound to be tested with a 16386, 15402, 21165, 1423, 636, 12303, 21425, 27410, 38554, 38555, 55063, 57145, 59914, 94921, 16852, 33260, 58573, 30911, 85913, 14303, 16816, 17827 or 32620 polypeptide for binding of the test compound to the polypeptide; detecting binding for pain treatment |
| 01/30/2007 | US7169585 Papillomavirus vaccine |
| 01/30/2007 | US7169572 Assays for determining anticoagulant cofactor activity |
| 01/30/2007 | US7169559 Using low density lipoprotein related proteins (LRP) to diagnose, treat and prevent paget's, osteoporosis, cirrhosis and rickets |
| 01/30/2007 | US7169399 Administering intranasally an antigen which is a non-toxic double mutant form of pertussis toxin inducing an immune response |
| 01/30/2007 | US7169398 Equine protozoal myeloencephalitis vaccine |
| 01/30/2007 | US7169397 equine influenza virus genome segment confers at least one identifying phenotype of a cold-adapted equine influenza virus on the reassortant virus, and genetically-engineered equine influenza viruses, produced through reverse genetics |
| 01/30/2007 | US7169396 nucleotide sequences of the genomes of eleven molecular clones for non-subtype B isolates of human immunodeficiency virus type 1; vaccine |
| 01/30/2007 | US7169395 combining a mixture of RSV proteins with non-virulent influenza virus in a vaccine formulation provides an immune response which is substantially the same as the response obtained by administration of the components individually |
| 01/30/2007 | US7169394 Also contains an antigen of swine influenza virus, porcine reproductive and respiratory syndrome virus, or porcine circovirus; an acrylic acid polymer, metabolizable oil and an oxyethylene-oxypropylene block polymer as adjuvant |
| 01/30/2007 | US7169393 Antigenic peptide fragments of VapA protein, and uses thereof |
| 01/30/2007 | US7169392 Vaccine complex; forming antibodies |
| 01/30/2007 | US7169391 Oil in water emulsions; induction immunology response; antigens |
| 01/30/2007 | US7169390 Administering an agent binds a sphingolipid or a sphingolipid metabolite, especially an antibody or derivative, a receptor of a sphingolipid or a sphingolipid metabolite. |
| 01/30/2007 | US7169389 Human CD154 binding molecules and treatment methods |
| 01/30/2007 | US7169388 unexpected discovery that the inhibition or antagonism of TNF decreases the expression of Vascular Endothelial Growth Factor (VEGF) or Vascular Permeability Factor (VPF). VEGF has been implicated in the angiogenesis in cancer, vascular diseases and rheumatoid arthritis |
| 01/30/2007 | US7169387 Monoclonal antibodies orsoluble immunoglobulin fusion protein; block multiple sclerosis |
| 01/30/2007 | US7169386 Chimeric immunoglobulin; for the diagnosis and treatment of bacterail infection, cancer and septic shock |
| 01/30/2007 | US7169383 Attaching substances to micro-organisms |
| 01/30/2007 | CA2351553C Transgenic animals |
| 01/30/2007 | CA2210751C Anti-cd6 monoclonal antibodies and their uses |
| 01/30/2007 | CA2167693C Melanoma-inhibiting protein |
| 01/30/2007 | CA2107537C Inhibition of tumor cell growth by administration of b7-transfected cells |
| 01/30/2007 | CA1341520C Peptides capable of binding hiv (human immunodeficiency virus) antibodies, their use in diagnosis hiv infections, or for aids vaccination |
| 01/25/2007 | WO2007011993A1 Lawsonia vaccine and methods of use thereof |
| 01/25/2007 | WO2007011968A2 Beta-glucuronide-linker drug conjugates |
| 01/25/2007 | WO2007011960A2 Methods and agents to treat autoimmune diseases |
| 01/25/2007 | WO2007011941A2 Human anti-b7rp1 neutralizing antibodies |
| 01/25/2007 | WO2007011907A2 Alpha-synuclein antibodies and methods related thereto |
| 01/25/2007 | WO2007011904A2 Recombinant flu vaccines |
| 01/25/2007 | WO2007011896A2 Method to inhibit proliferation and growth of metastases |
| 01/25/2007 | WO2007011873A2 Method for treating intraocular neovascular diseases |